Breaking News Instant updates and real-time market news.

PACB

Pacific Biosciences

$9.05

0.18 (2.03%)

, ILMN

Illumina

$184.85

0.36 (0.20%)

17:13
10/10/16
10/10
17:13
10/10/16
17:13

Pacific Biosciences down 4.4%, QIAGEN down 1.8% after Illumina warning

PACB

Pacific Biosciences

$9.05

0.18 (2.03%)

ILMN

Illumina

$184.85

0.36 (0.20%)

QGEN

QIAGEN

$27.57

0.19 (0.69%)

A

Agilent

$47.69

0.31 (0.65%)

  • 10

    Oct

  • 01

    Nov

PACB Pacific Biosciences
$9.05

0.18 (2.03%)

04/22/16
CANT
04/22/16
NO CHANGE
CANT
Pacific Biosciences should be bought after strong Q1 results, says Cantor
Cantor recommends that investors buy the shares of Pacific Biosciences after the company reported stronger than expected Q1 results. The firm thinks that the company's increased guidance may be conservative, and it believes that the company could have at least 30 bookings in Q2. Cantor keeps an $18 price target and Buy rating on the shares.
04/18/16
PIPR
04/18/16
NO CHANGE
Target $11
PIPR
Neutral
Pacific Biosciences estimates lowered on Sequel checks at Piper Jaffray
Piper Jaffray analyst William Quirk lowered his Q1 estimates for Pacific Biosciences after his initial round of Sequel channel checks found six placements during the quarter compared to the 17 he modeled. Assuming Roche placed five systems, the Q1 total would come to 11, Quirk tells investors in a research note. The analyst keeps a Neutral rating on the shares with an $11 price target.
08/04/16
08/04/16
NO CHANGE

On The Fly: After Hours Movers
UP AFTER EARNINGS: Pacific Biosciences (PACB), up 17%... MasTec (MTZ), up 9.6%... Aratana Therapeutics (PETX), up 9.2%... Lion's Gate (LGF), up 6.4%... Priceline (PCLN), up 5.7%... Ubiquiti (UBNT), up 5.5%... MercadoLibre (MELI), up 4.1%... Organovo (ONVO), up 3.9%... Kraft Heinz (KHC), up 3.3%... EOG Resources (EOG), up 2.8%... Monster Beverage (MNST), up 1.2%... TASER (TASR), up 1.2%... Take-Two (TTWO), up 0.9%... Activision Blizzard (ATVI), up 1%... BioMarin (BMRN), up 0.4%. ALSO HIGHER: Egalet (EGLT), up 31.2% after the company announced that an FDA advisory committee recommended approval of its ARYMO ER drug... Rackspace (RAX), up 17.6% after the Wall Street Journal reported that the company was near a takeover deal with a private equity buyer... Osiris (OSIR), up 8.5% after it said that the manuscript from its prospective trial using Grafix was published. DOWN AFTER EARNINGS: Hortonworks (HDP), down 26.2%... PDL BioPharma (PDLI), down 17.5%... FireEye (FEYE), down 15.8%... Sierra Wireless (SWIR), down 15.6%... Aquinox (AQXP), down 14.7%... Zynga (ZNGA), down 9.4%... Universal Display (OLED), down 8.2%... Weight Watchers (WTW), down 7.6%... Zillow Group (Z, ZG), down 5.5%... Arista Networks (ANET), down 4.5%... Noodles & Company (NDLS), down 4.3%... Merrimack (MACK), down 1.7%... Bankrate (RATE), down 1.7%.
08/18/16
CANT
08/18/16
NO CHANGE
Target $165
CANT
Speculative Buy
Thermo Fisher unlikely to acquire Illumina, says Cantor
Cantor Fitzgerald analyst Bryan Brokmeier believes it is unlikely that Thermo Fisher (TMO) will attempt to acquire Illumina (ILMN). Even if Thermo were to attempt a deal, the merger would be unlikely to close, Brokmeier tells investors in an intraday research note. If Illumina is a willing seller, however, Roche (RHHBY) may reconsider a bid, the analyst contends. He recommends investors stay on the sidelines with respect to Illumina shares. Brokmeier has a Hold rating on the name with a $165 price target. The analyst continues to believe Roche is the most likely acquirer of Pacific Biosciences (PACB).
ILMN Illumina
$184.85

0.36 (0.20%)

08/22/16
KING
08/22/16
DOWNGRADE
KING
Neutral
Illumina downgraded to Neutral from Buy at CL King
CL King analyst David Westenberg downgraded Illumina to Neutral given the recent run-up in the shares and lack of near-term visible catalysts.
08/18/16
WELS
08/18/16
NO CHANGE
WELS
Wells Fargo says Thermo Fisher buying Illumina 'makes no sense'
Wells Fargo analyst Tim Evans believes speculation of Thermo Fisher (TMO) acquiring Illumina "makes no sense." The analyst estimates the deal would be about 14% dilutive to Thermo in year one and "would struggle to be neutral" to earnings by year three. Further, the deal would run into "significant regulatory hurdles" since that Illumina holds a near monopoly in high-throughput sequencing, Evans tell investors note. Shares of Illumina are off their highs but remain up 3% after StreetInsider stoked renewed takeout speculation by citing a source saying Thermo may bid $30B for the company.
09/12/16
SBSH
09/12/16
NO CHANGE
Target $190
SBSH
Buy
Illumina price target raised to $190 from $175 at Citi
Citi analyst Daniel Arias raised his price target for Illumina to $190 after traveling with the company's CFO Marc Stapley and investor relations head Rebecca Chambers. The analyst believes the business "can hold its own" in the second half of 2016 and that shares can move higher in 2017. He keeps a Buy rating on Illumina.
QGEN QIAGEN
$27.57

0.19 (0.69%)

11/12/15
STFL
11/12/15
INITIATION
STFL
Hold
QIAGEN initiated with a Hold at Stifel
05/25/16
PIPR
05/25/16
NO CHANGE
PIPR
Neutral
Piper says QIAGEN may need to change or pull GeneReader if Illumina wins suit
Piper Jaffray analyst William Quirk said patent infringement outcomes are hard to predict, but added that Illumina's (ILMN) win at the Patent Trial and Appeal Board increase its chances to prevail in its recently filed infringement lawsuit against Qiagen (QGEN) related to the GeneReader DNA sequencer. If Illumina does win, Qiagen will need to "drastically" alter the product and/or remove it from the market, said Quirk, who keeps a Neutral rating on Qiagen shares.
08/01/16
HSBC
08/01/16
UPGRADE
HSBC
Buy
QIAGEN upgraded to Buy from Hold at HSBC
HSBC analyst Keppeler upgraded QIAGEN to Buy and increased its price target to $27 from $20. The analyst is more constructive on improving trends in Academia/Pharma and expects topline growth to accelerate to 7% in 2017 from 1-4% in 2012-2015 from strong growth drivers that include QiaSymphony instrument and the NGS franchise.
11/12/15
11/12/15
INITIATION

On The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Accuray (ARAY) initiated with a Sell at Citi... Becton Dickinson (BDX) initiated with a Neutral at Citi... Boston Scientific (BSX) initiated with a Buy at Citi... Bruker (BRKR) initiated with a Buy at Stifel... C.R. Bard (BCR) initiated with a Buy at Citi... Cepheid (CPHD) initiated with a Buy at Stifel... CorMedix (CRMD) initiated with a Buy at Rodman & Renshaw... CoreSite Realty (COR) initiated with a Buy at BB&T... Digital Realty (DLR) initiated with a Buy at BB&T... DuPont Fabros (DFT) initiated with a Hold at BB&T... Duke Realty (DRE) initiated with a Hold at BB&T... Edwards Lifesciences (EW) initiated with a Sell at Citi... Electronic Arts (EA) initiated with an Outperform at Oppenheimer... EyeGate (EYEG) initiated with a Buy at Maxim... Glu Mobile (GLUU) initiated with a Perform at Oppenheimer... Integra LifeSciences (IART) initiated with a Buy at Citi... Intuitive Surgical (ISRG) initiated with a Buy at Citi... Mast Therapeutics (MSTX) initiated with a Buy at Maxim... Medgenics (MDGN) initiated with a Buy at Needham... Novocure (NVCR) initiated with a Buy at Evercore ISI... Prologis (PLD) initiated with a Hold at BB&T... QIAGEN (QGEN) initiated with a Hold at Stifel... Rocket Fuel (FUEL) initiated with a Neutral at Boenning & Scattergood... STAG Industrial (STAG) initiated with an Underweight at BB&T... Stryker (SYK) initiated with a Sell at Citi... Tremor Video (TRMR) initiated with an Outperform at Boenning & Scattergood... VOXX (VOXX) initiated with an Outperform at Oppenheimer... Varian Medical (VAR) initiated with a Neutral at Citi... Yahoo (YHOO) initiated with an Outperform at Boenning & Scattergood... YuMe (YUME) initiated with a Neutral at Boenning & Scattergood... Zimmer Biomet (ZBH) initiated with a Sell at Citi.
A Agilent
$47.69

0.31 (0.65%)

05/23/16
JANY
05/23/16
NO CHANGE
JANY
Buy
Janney says Thermo Fisher not buying Agilent, but names some other targets
In a note to investors published Friday afternoon, Janney Capital analyst Paul Knight said he was surprised that Thermo Fisher (TMO) said at its analyst day that it intends to spend at least 70% of deployed capital, or $12B over four years, on M&A, noting he expected more buybacks. Knight said Agilent (A) is often mentioned as a Thermo target, but he does not see that deal happening given the antitrust hurdles. Knight said Thermo is likely to acquire in the biological production space, where there are limited candidates, and noted that Repligen (RGEN) "possesses a near monopoly" in Protein A ligands. There are also "easy adds" in biological reagents, Knight tells investors, noting that Bio-Techne (TECH) is one of the two leading reagent companies for research proteins and antibodies. The firm has a Buy rating on Thermo Fisher shares.
05/17/16
EVER
05/17/16
NO CHANGE
Target $48
EVER
Buy
Agilent price target raised to $48 on strong Q2 print at Evercore ISI
Evercore ISI analyst Ross Muken raised Agilent's price target to $48 from $43 citing the strong Q2 report driven by HSD core revenue growth, solid OMx exeuction, and impressive uptick free cash flow, and the guidance raise. Muken has increased confidence in execution and upside to his forecasts, and reiterates his Buy rating.
05/17/16
JANY
05/17/16
NO CHANGE
Target $52
JANY
Buy
Agilent current quarter guidance looks conservative, says Janney Capital
Janney Capital analyst Paul Knight said Agilent's results beat expectations on "every line" in the April quarter and he believes the company's guidance for the current quarter looks conservative. Knight, who expects tailwinds as academia improves and China gains visibility, raised his fair value estimate on Agilent shares to $52 from $45 and keeps a Buy rating on the name.
05/25/16
LEER
05/25/16
NO CHANGE
LEER
Outperform
Agilent analyst day reinforces margin expansion opportunity, says Leerink
Leerink analyst Dan Leonard said today's analyst day meeting held by Agilent reinforced his view that the company has more margin expansion opportunity that is "top-line independent" than its peers in the Life Science Tools space. The company's articulation of an opportunity to reduce its effective tax rate by 200bps over the next two years was an unexpected "nice surprise," added Leonard, who keeps an Outperform rating on the stock.

TODAY'S FREE FLY STORIES

NRZ

New Residential

$16.85

0.31 (1.87%)

13:46
04/26/17
04/26
13:46
04/26/17
13:46
Options
New Residential call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

PGH

Pengrowth Energy

$1.01

-0.0065 (-0.64%)

13:45
04/26/17
04/26
13:45
04/26/17
13:45
Upgrade
Pengrowth Energy rating change  »

Pengrowth Energy upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SXL

Sunoco Logistics

$24.29

-0.065 (-0.27%)

, ETP

Energy Transfer Partners

$36.37

-0.05 (-0.14%)

13:43
04/26/17
04/26
13:43
04/26/17
13:43
Hot Stocks
Energy Transfer Partners holders approve Sunoco Logistics merger »

Sunoco Logistics Partners…

SXL

Sunoco Logistics

$24.29

-0.065 (-0.27%)

ETP

Energy Transfer Partners

$36.37

-0.05 (-0.14%)

ETE

Energy Transfer Equity

$19.33

0.78 (4.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 23

    May

XOM

Exxon Mobil

$81.98

0.25 (0.31%)

13:43
04/26/17
04/26
13:43
04/26/17
13:43
Hot Stocks
Exxon Mobil raises dividend to 77c from 75c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

ATVI

Activision Blizzard

$51.36

0.48 (0.94%)

13:39
04/26/17
04/26
13:39
04/26/17
13:39
Hot Stocks
Activision Blizzard unveils next 'Call of Duty,' says launching November 3 »

Activision Blizzard…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

  • 09

    May

NTRA

Natera

$8.62

0.26 (3.11%)

13:33
04/26/17
04/26
13:33
04/26/17
13:33
Hot Stocks
Natera, Cancer Research UK publish results from 100 patients in TRACERx study »

Natera and Cancer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

HCLP

Hi-Crush Partners

$15.05

-0.05 (-0.33%)

13:33
04/26/17
04/26
13:33
04/26/17
13:33
Options
Hi Crush Partners calls are active ahead of earnings »

Hi Crush Partners calls…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

NFLX

Netflix

$152.16

8.33 (5.79%)

, FB

Facebook

$146.49

1.02 (0.70%)

13:32
04/26/17
04/26
13:32
04/26/17
13:32
Hot Stocks
FCC chairman Pai proposes to roll back net neutrality rules »

As previewed in recent…

NFLX

Netflix

$152.16

8.33 (5.79%)

FB

Facebook

$146.49

1.02 (0.70%)

AMZN

Amazon.com

$907.62

0.21 (0.02%)

GOOG

Alphabet

$872.30

9.54 (1.11%)

GOOGL

Alphabet Class A

$888.84

9.91 (1.13%)

CMCSA

Comcast

$38.49

0.48 (1.26%)

CMCSK

Comcast

T

AT&T

$40.11

0.17 (0.43%)

VZ

Verizon

$47.29

0.5937 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 03

    May

  • 08

    May

  • 09

    May

  • 16

    May

  • 16

    May

  • 16

    May

  • 17

    May

  • 22

    May

  • 23

    May

  • 05

    Jun

MPLX

MPLX

$36.39

-0.26 (-0.71%)

13:31
04/26/17
04/26
13:31
04/26/17
13:31
Hot Stocks
MPLX raises quarterly distribution 4% to 54c per unit »

MPLX LP announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

CREE

Cree

$24.82

0.07 (0.28%)

, IFNNY

Infineon

$20.70

0.12 (0.58%)

13:29
04/26/17
04/26
13:29
04/26/17
13:29
Recommendations
Cree, Infineon analyst commentary  »

Roth Capital says Cree…

CREE

Cree

$24.82

0.07 (0.28%)

IFNNY

Infineon

$20.70

0.12 (0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 03

    May

  • 09

    May

IART

Integra LifeSciences

$43.74

0.86 (2.01%)

13:27
04/26/17
04/26
13:27
04/26/17
13:27
Recommendations
Integra LifeSciences analyst commentary  »

Integra LifeSciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 06

    Jun

AA

Alcoa

$36.37

-0.12 (-0.33%)

, KALU

Kaiser Aluminum

$83.84

-0.05 (-0.06%)

13:26
04/26/17
04/26
13:26
04/26/17
13:26
Periodicals
Commerce Secretary to announce plan to investigate aluminum imports, CNBC says »

Commerce Secretary Wilbur…

AA

Alcoa

$36.37

-0.12 (-0.33%)

KALU

Kaiser Aluminum

$83.84

-0.05 (-0.06%)

CENX

Century Aluminum

$13.62

0.99 (7.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZIOP

ZIOPHARM

$7.09

0.25 (3.66%)

13:26
04/26/17
04/26
13:26
04/26/17
13:26
Options
Ziopharm call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    May

  • 01

    May

  • 02

    Jun

  • 06

    Jun

13:20
04/26/17
04/26
13:20
04/26/17
13:20
General news
Treasury Action: yields jerked higher »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

13:17
04/26/17
04/26
13:17
04/26/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
04/26/17
04/26
13:16
04/26/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
04/26/17
04/26
13:15
04/26/17
13:15
General news
5-Yr Note Auction Coupon Rate data reported »

5-Yr Note Auction Coupon…

13:15
04/26/17
04/26
13:15
04/26/17
13:15
General news
Treasury's $34 B 5-year sale was poor, as feared »

Treasury's $34 B…

13:14
04/26/17
04/26
13:14
04/26/17
13:14
General news
5-Yr Note Auction Total Amount data reported »

5-Yr Note Auction Total…

13:14
04/26/17
04/26
13:14
04/26/17
13:14
General news
Export Prices data reported. »

April Export Prices at % …

13:14
04/26/17
04/26
13:14
04/26/17
13:14
General news
Import Prices data reported. »

April Import Prices at % …

EEM

MSCI Emerging Markets Index

$40.04

-0.16 (-0.40%)

13:11
04/26/17
04/26
13:11
04/26/17
13:11
Options
Notable put spreads in the iShares Emerging Markets ETF »

Notable put spreads in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$227.78

1.15 (0.51%)

, BAC

Bank of America

$24.08

0.095 (0.40%)

13:08
04/26/17
04/26
13:08
04/26/17
13:08
Periodicals
Fed looks to restructure big bank supervision panel, WSJ says »

The Fed is restructuring…

GS

Goldman Sachs

$227.78

1.15 (0.51%)

BAC

Bank of America

$24.08

0.095 (0.40%)

C

Citi

$60.43

0.2199 (0.37%)

WFC

Wells Fargo

$54.90

0.335 (0.61%)

JPM

JPMorgan

$88.61

0.345 (0.39%)

MS

Morgan Stanley

$44.65

0.38 (0.86%)

USB

U.S. Bancorp

$52.36

0.225 (0.43%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 26

    Apr

  • 09

    May

  • 11

    May

  • 19

    May

  • 22

    May

  • 31

    May

  • 06

    Jun

  • 13

    Jul

  • 14

    Jul

  • 18

    Jul

  • 19

    Jul

  • 25

    Jul

  • 12

    Oct

  • 12

    Oct

  • 17

    Oct

  • 18

    Oct

  • 15

    Jan

  • 17

    Jan

  • 13

    Apr

  • 13

    Jul

  • 12

    Oct

X

U.S. Steel

$23.27

-7.84 (-25.20%)

13:06
04/26/17
04/26
13:06
04/26/17
13:06
Downgrade
U.S. Steel rating change  »

U.S. Steel downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

CCCR

China Commercial Credit

$1.82

0.4101 (29.09%)

13:06
04/26/17
04/26
13:06
04/26/17
13:06
Syndicate
Breaking Syndicate news story on China Commercial Credit »

China Commercial Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.